Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic vitrectomy: risks, prognosis, future trends.

John O Mason1, Cheri T Colagross, Rachel Vail

  • 1Department of Ophthalmology, University of Alabama at Birmingham School of Medicine, Callahan Eye Foundation Hospital, Birmingham, Alabama 35233, USA.

Current Opinion in Ophthalmology
|June 24, 2006
PubMed
Summary

Diabetic pars plana vitrectomy offers improved outcomes for diabetic eye disease. Advances in surgical techniques and pharmacotherapy are revolutionizing treatment, enhancing both anatomical and visual success.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REST deficiency and neurogenic-to-gliogenic shift in down syndrome human cerebral organoids.

Molecular brain·2026
Same author

Protocol for the establishment and morphological characterization of long-term cultivated murine cerebral organoids.

STAR protocols·2026
Same author

Early genetic evolution of driver mutations in uveal melanoma.

Nature communications·2025
Same author

Long-Term Outcomes on Quality of Life Following Sutureless Vitrectomy for Symptomatic Vitreous Floaters.

Journal of vitreoretinal diseases·2025
Same author

Cerebral Organoids with Integrated Endothelial Networks Emulate the Neurovascular Unit and Mitigate Core Necrosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Up to ten years of visual acuity outcomes in fellow eyes post-uveal melanoma treatment with iodine-125 radiotherapy, transpupillary thermotherapy, and proton beam therapy.

Journal of contemporary brachytherapy·2025

Area of Science:

  • Ophthalmology
  • Diabetic Retinopathy Management

Background:

  • Diabetic eye disease presents significant challenges, including diabetic macular edema and traction retinal detachment.
  • Current treatments aim to manage these complications, but advancements are continuously sought.

Purpose of the Study:

  • To review current standards, risks, prognosis, and indications for diabetic pars plana vitrectomy.
  • To examine the role of vitrectomy alongside other treatment modalities for diabetic eye disease.

Main Methods:

  • Review of current standards and recent developments in surgical techniques for diabetic pars plana vitrectomy.
  • Examination of pharmacotherapy, including systemic and intravitreal approaches.

Main Results:

  • Pars plana vitrectomy is effective for diabetic macular edema and traction retinal detachment.

Related Experiment Videos

  • Smaller gauge vitrectors (25- and 23-gauge) offer reduced trauma and faster healing.
  • New techniques aim to prevent postoperative vitreous hemorrhage through cryotherapy and endolaser.
  • Pharmacological advances target glycemic control, retinal metabolism, and neuroprotection/vasoprotection.

    • Conclusions:

    • Combined therapies and evolving interventions have the potential to revolutionize diabetic eye disease management.
    • Diabetic pars plana vitrectomy demonstrates ongoing advancements with improved anatomical and visual success.